PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
4.03
P/E of 4.03 versus zero earnings in Healthcare. Walter Schloss would verify earnings quality.
0.40
P/S less than half the Healthcare median of 6.98. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
0.93
P/B 50-90% of Healthcare median of 1.79. Mohnish Pabrai would examine if this discount presents opportunity.
10.49
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash flow generation advantage.
6.32
P/OCF of 6.32 versus zero operating cash flow in Healthcare. Walter Schloss would verify operational quality.
0.93
Fair value ratio 50-90% of Healthcare median of 1.76. Mohnish Pabrai would examine if this gap presents opportunity.
6.20%
Earnings yield exceeding 1.5x Healthcare median of 0.05%. Joel Greenblatt would investigate if high yield reflects hidden value.
9.53%
Positive FCF while Healthcare median shows negative FCF. Peter Lynch would examine cash generation advantage.